Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Proteomics Analysis of Formalin Fixed Paraffin Embedded Tissues in the Investigation of Prostate Cancer.

Mantsiou A, Makridakis M, Fasoulakis K, Katafigiotis I, Constantinides CA, Zoidakis J, Roubelakis MG, Vlahou A, Lygirou V.

J Proteome Res. 2019 Nov 18. doi: 10.1021/acs.jproteome.9b00587. [Epub ahead of print]

PMID:
31682457
2.

High resolution analysis of the intracellular proteome of cervical cancer cell lines unveils novel regulators of cervical carcinogenesis.

Pappa KI, Lygirou V, Kontostathi G, Makridakis M, Vougas K, Sfakianakis A, Daskalakis G, Zoidakis J, Anagnou NP.

Oncol Rep. 2019 Aug 8. doi: 10.3892/or.2019.7269. [Epub ahead of print]

PMID:
31524267
3.

Short Term Results of Fibrin Gel Obtained from Cord Blood Units: A Preliminary in Vitro Study.

Mallis P, Gontika I, Dimou Z, Panagouli E, Zoidakis J, Makridakis M, Vlahou A, Georgiou E, Gkioka V, Stavropoulos-Giokas C, Michalopoulos E.

Bioengineering (Basel). 2019 Aug 2;6(3). pii: E66. doi: 10.3390/bioengineering6030066.

4.

Proteome-based classification of Nonmuscle Invasive Bladder Cancer.

Stroggilos R, Mokou M, Latosinska A, Makridakis M, Lygirou V, Mavrogeorgis E, Drekolias D, Frantzi M, Mullen W, Fragkoulis C, Stasinopoulos K, Papadopoulos G, Stathouros G, Lazaris AC, Makrythanasis P, Ntoumas K, Mischak H, Zoidakis J, Vlahou A.

Int J Cancer. 2020 Jan 1;146(1):281-294. doi: 10.1002/ijc.32556. Epub 2019 Jul 26.

PMID:
31286493
5.

Applications of multiple reaction monitoring targeted proteomics assays in human plasma.

Kontostathi G, Makridakis M, Zoidakis J, Vlahou A.

Expert Rev Mol Diagn. 2019 Jun;19(6):499-515. doi: 10.1080/14737159.2019.1615448. Epub 2019 May 17.

PMID:
31057016
6.

Implications of the mitochondrial interactome of mammalian thioredoxin 2 for normal cellular function and disease.

Chasapis CT, Makridakis M, Damdimopoulos AE, Zoidakis J, Lygirou V, Mavroidis M, Vlahou A, Miranda-Vizuete A, Spyrou G, Vlamis-Gardikas A.

Free Radic Biol Med. 2019 Jun;137:59-73. doi: 10.1016/j.freeradbiomed.2019.04.018. Epub 2019 Apr 21.

PMID:
31018154
7.

Protein biomarkers for cardiorenal syndrome.

Petra E, Zoidakis J, Vlahou A.

Expert Rev Proteomics. 2019 Apr;16(4):325-336. doi: 10.1080/14789450.2019.1592682. Epub 2019 Mar 22.

PMID:
30855192
8.

Development and Validation of Multiple Reaction Monitoring (MRM) Assays for Clinical Applications.

Kontostathi G, Makridakis M, Bitsika V, Tsolakos N, Vlahou A, Zoidakis J.

Methods Mol Biol. 2019;1959:205-223. doi: 10.1007/978-1-4939-9164-8_14.

PMID:
30852825
9.

Proteomics based identification of KDM5 histone demethylases associated with cardiovascular disease.

Mokou M, Klein J, Makridakis M, Bitsika V, Bascands JL, Saulnier-Blache JS, Mullen W, Sacherer M, Zoidakis J, Pieske B, Mischak H, Roubelakis MG, Schanstra JP, Vlahou A.

EBioMedicine. 2019 Mar;41:91-104. doi: 10.1016/j.ebiom.2019.02.040. Epub 2019 Feb 28.

10.

Diagnostic and Prognostic Performance of Secreted Protein Acidic and Rich in Cysteine (SPARC) Assay for Detecting Primary and Recurrent Urinary Bladder Cancer.

Critselis E, Rava M, Marquez M, Lygirou V, Chatzicharalambous D, Liapi P, Lichtinghagen R, Brand K, Cecchini L, Vlahou A, Malats N, Zoidakis J.

Proteomics Clin Appl. 2019 Mar;13(2):e1800148. doi: 10.1002/prca.201800148. Epub 2019 Jan 30.

PMID:
30632279
11.

Systematic review on recent potential biomarkers of chronic obstructive pulmonary disease.

Aydindogan E, Penque D, Zoidakis J.

Expert Rev Mol Diagn. 2019 Jan;19(1):37-45. doi: 10.1080/14737159.2018.1559054. Epub 2018 Dec 18.

PMID:
30560707
12.

Proteome of olive non-glandular trichomes reveals protective protein network against (a)biotic challenge.

Roka L, Koudounas K, Daras G, Zoidakis J, Vlahou A, Kalaitzis P, Hatzopoulos P.

J Plant Physiol. 2018 Dec;231:210-218. doi: 10.1016/j.jplph.2018.09.016. Epub 2018 Sep 27.

PMID:
30286324
13.

Membrane proteomics of cervical cancer cell lines reveal insights on the process of cervical carcinogenesis.

Pappa KI, Christou P, Xholi A, Mermelekas G, Kontostathi G, Lygirou V, Makridakis M, Zoidakis J, Anagnou NP.

Int J Oncol. 2018 Nov;53(5):2111-2122. doi: 10.3892/ijo.2018.4518. Epub 2018 Aug 7.

PMID:
30106135
14.

The family of 14-3-3 proteins and specifically 14-3-3σ are up-regulated during the development of renal pathologies.

Rizou M, Frangou EA, Marineli F, Prakoura N, Zoidakis J, Gakiopoulou H, Liapis G, Kavvadas P, Chatziantoniou C, Makridakis M, Vlahou A, Boletis J, Vlahakos D, Goumenos D, Daphnis E, Iatrou C, Charonis AS.

J Cell Mol Med. 2018 Sep;22(9):4139-4149. doi: 10.1111/jcmm.13691. Epub 2018 Jun 28.

15.

Tissue proteomics studies in the investigation of prostate cancer.

Mantsiou A, Vlahou A, Zoidakis J.

Expert Rev Proteomics. 2018 Jul;15(7):593-611. doi: 10.1080/14789450.2018.1491796. Epub 2018 Jul 16. Review.

PMID:
29939814
16.

Saliva Proteomics Analysis Offers Insights on Type 1 Diabetes Pathology in a Pediatric Population.

Pappa E, Vastardis H, Mermelekas G, Gerasimidi-Vazeou A, Zoidakis J, Vougas K.

Front Physiol. 2018 Apr 26;9:444. doi: 10.3389/fphys.2018.00444. eCollection 2018.

17.

Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease.

Lygirou V, Latosinska A, Makridakis M, Mullen W, Delles C, Schanstra JP, Zoidakis J, Pieske B, Mischak H, Vlahou A.

J Transl Med. 2018 Apr 17;16(1):104. doi: 10.1186/s12967-018-1476-9.

18.

Evaluation of Peripheral Blood and Cord Blood Platelet Lysates in Isolation and Expansion of Multipotent Mesenchymal Stromal Cells.

Christou I, Mallis P, Michalopoulos E, Chatzistamatiou T, Mermelekas G, Zoidakis J, Vlahou A, Stavropoulos-Giokas C.

Bioengineering (Basel). 2018 Feb 26;5(1). pii: E19. doi: 10.3390/bioengineering5010019.

19.

Novel structural approaches concerning HPV proteins: Insight into targeted therapies for cervical cancer (Review).

Pappa KI, Kontostathi G, Lygirou V, Zoidakis J, Anagnou NP.

Oncol Rep. 2018 Apr;39(4):1547-1554. doi: 10.3892/or.2018.6257. Epub 2018 Feb 9. Review.

PMID:
29436691
20.

Proteomics and Metabolomics for AKI Diagnosis.

Marx D, Metzger J, Pejchinovski M, Gil RB, Frantzi M, Latosinska A, Belczacka I, Heinzmann SS, Husi H, Zoidakis J, Klingele M, Herget-Rosenthal S.

Semin Nephrol. 2018 Jan;38(1):63-87. doi: 10.1016/j.semnephrol.2017.09.007. Review.

PMID:
29291763
21.

Chloride Intracellular Channel 4 Overexpression in the Proximal Tubules of Kidneys from the Spontaneously Hypertensive Rat: Insight from Proteomic Analysis.

Hatziioanou D, Barkas G, Critselis E, Zoidakis J, Gakiopoulou H, Androutsou ME, Drossopoulou G, Charonis A, Vlahakos DV.

Nephron. 2018;138(1):60-70. doi: 10.1159/000479169. Epub 2017 Nov 7.

PMID:
29131056
22.

Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy.

Krochmal M, Kontostathi G, Magalhães P, Makridakis M, Klein J, Husi H, Leierer J, Mayer G, Bascands JL, Denis C, Zoidakis J, Zürbig P, Delles C, Schanstra JP, Mischak H, Vlahou A.

Sci Rep. 2017 Nov 9;7(1):15160. doi: 10.1038/s41598-017-15359-9.

23.

High Resolution Proteomic Analysis of the Cervical Cancer Cell Lines Secretome Documents Deregulation of Multiple Proteases.

Pappa KI, Kontostathi G, Makridakis M, Lygirou V, Zoidakis J, Daskalakis G, Anagnou NP.

Cancer Genomics Proteomics. 2017 Nov-Dec;14(6):507-521. Review.

24.

Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.

Latosinska A, Mokou M, Makridakis M, Mullen W, Zoidakis J, Lygirou V, Frantzi M, Katafigiotis I, Stravodimos K, Hupe MC, Dobrzynski M, Kolch W, Merseburger AS, Mischak H, Roubelakis MG, Vlahou A.

Oncotarget. 2017 Apr 20;8(41):69435-69455. doi: 10.18632/oncotarget.17279. eCollection 2017 Sep 19.

25.

Urinary Proteomics in Predicting Heart Transplantation Outcomes (uPROPHET)-Rationale and database description.

Huang QF, Trenson S, Zhang ZY, Yang WY, Van Aelst L, Nkuipou-Kenfack E, Wei FF, Mujaj B, Thijs L, Ciarka A, Zoidakis J, Droogné W, Vlahou A, Janssens S, Vanhaecke J, Van Cleemput J, Staessen JA.

PLoS One. 2017 Sep 7;12(9):e0184443. doi: 10.1371/journal.pone.0184443. eCollection 2017.

26.

Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysis.

Krochmal M, Cisek K, Filip S, Markoska K, Orange C, Zoidakis J, Gakiopoulou C, Spasovski G, Mischak H, Delles C, Vlahou A, Jankowski J.

Sci Rep. 2017 Aug 22;7(1):9091. doi: 10.1038/s41598-017-09393-w.

27.

Proteomic Analysis of Normal and Cancer Cervical Cell Lines Reveals Deregulation of Cytoskeleton-associated Proteins.

Pappa KI, Lygirou V, Kontostathi G, Zoidakis J, Makridakis M, Vougas K, Daskalakis G, Polyzos A, Anagnou NP.

Cancer Genomics Proteomics. 2017 Jul-Aug;14(4):253-266.

28.

Cervical Cancer Cell Line Secretome Highlights the Roles of Transforming Growth Factor-Beta-Induced Protein ig-h3, Peroxiredoxin-2, and NRF2 on Cervical Carcinogenesis.

Kontostathi G, Zoidakis J, Makridakis M, Lygirou V, Mermelekas G, Papadopoulos T, Vougas K, Vlamis-Gardikas A, Drakakis P, Loutradis D, Vlahou A, Anagnou NP, Pappa KI.

Biomed Res Int. 2017;2017:4180703. doi: 10.1155/2017/4180703. Epub 2017 Feb 2.

29.

Simple and Efficient Stratification of Invasive Bladder Cancer Patients.

Zoidakis J.

EBioMedicine. 2016 Oct;12:6-7. doi: 10.1016/j.ebiom.2016.08.041. Epub 2016 Aug 28. No abstract available.

30.

Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer models.

Frantzi M, Klimou Z, Makridakis M, Zoidakis J, Latosinska A, Borràs DM, Janssen B, Giannopoulou I, Lygirou V, Lazaris AC, Anagnou NP, Mischak H, Roubelakis MG, Vlahou A.

Oncotarget. 2016 Oct 25;7(43):70750-70768. doi: 10.18632/oncotarget.12218.

31.

PeptiCKDdb-peptide- and protein-centric database for the investigation of genesis and progression of chronic kidney disease.

Krochmal M, Fernandes M, Filip S, Pontillo C, Husi H, Zoidakis J, Mischak H, Vlahou A, Jankowski J.

Database (Oxford). 2016 Sep 1;2016. pii: baw128. doi: 10.1093/database/baw128. Print 2016.

32.

Proteomics approaches in cervical cancer: focus on the discovery of biomarkers for diagnosis and drug treatment monitoring.

Kontostathi G, Zoidakis J, Anagnou NP, Pappa KI, Vlahou A, Makridakis M.

Expert Rev Proteomics. 2016 Aug;13(8):731-45. doi: 10.1080/14789450.2016.1210514. Review.

PMID:
27398979
33.

BcCluster: A Bladder Cancer Database at the Molecular Level.

Bhat A, Mokou M, Zoidakis J, Jankowski V, Vlahou A, Mischak H.

Bladder Cancer. 2016 Jan 7;2(1):65-76.

34.

Effect of Heme Oxygenase-1 Deficiency on Glomerular Proteomics.

Detsika MG, Lygirou V, Frantzis V, Zoidakis J, Atsaves V, Poulaki E, Gakiopoulou H, Vlahou A, Lianos EA.

Am J Nephrol. 2016;43(6):441-50. doi: 10.1159/000446859. Epub 2016 Jun 2.

PMID:
27251563
35.

Integrative analysis of extracellular and intracellular bladder cancer cell line proteome with transcriptome: improving coverage and validity of -omics findings.

Latosinska A, Makridakis M, Frantzi M, Borràs DM, Janssen B, Mullen W, Zoidakis J, Merseburger AS, Jankowski V, Mischak H, Vlahou A.

Sci Rep. 2016 May 11;6:25619. doi: 10.1038/srep25619.

36.

Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study.

Frantzi M, van Kessel KE, Zwarthoff EC, Marquez M, Rava M, Malats N, Merseburger AS, Katafigiotis I, Stravodimos K, Mullen W, Zoidakis J, Makridakis M, Pejchinovski M, Critselis E, Lichtinghagen R, Brand K, Dakna M, Roubelakis MG, Theodorescu D, Vlahou A, Mischak H, Anagnou NP.

Clin Cancer Res. 2016 Aug 15;22(16):4077-86. doi: 10.1158/1078-0432.CCR-15-2715. Epub 2016 Mar 29.

37.

Analytical Performance of ELISA Assays in Urine: One More Bottleneck towards Biomarker Validation and Clinical Implementation.

Chatziharalambous D, Lygirou V, Latosinska A, Stravodimos K, Vlahou A, Jankowski V, Zoidakis J.

PLoS One. 2016 Feb 18;11(2):e0149471. doi: 10.1371/journal.pone.0149471. eCollection 2016.

38.

Analysis of urinary cathepsin C for diagnosing Papillon-Lefèvre syndrome.

Hamon Y, Legowska M, Fergelot P, Dallet-Choisy S, Newell L, Vanderlynden L, Kord Valeshabad A, Acrich K, Kord H, Charalampos T, Morice-Picard F, Surplice I, Zoidakis J, David K, Vlahou A, Ragunatha S, Nagy N, Farkas K, Széll M, Goizet C, Schacher B, Battino M, Al Farraj Aldosari A, Wang X, Liu Y, Marchand-Adam S, Lesner A, Kara E, Korkmaz-Icöz S, Moss C, Eickholz P, Taieb A, Kavukcu S, Jenne DE, Gauthier F, Korkmaz B.

FEBS J. 2016 Feb;283(3):498-509. doi: 10.1111/febs.13605. Epub 2016 Jan 4.

39.

SRM/MRM targeted proteomics as a tool for biomarker validation and absolute quantification in human urine.

Mermelekas G, Vlahou A, Zoidakis J.

Expert Rev Mol Diagn. 2015;15(11):1441-54. doi: 10.1586/14737159.2015.1093937. Epub 2015 Oct 15. Review.

PMID:
26472065
40.

Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic Analysis.

Latosinska A, Vougas K, Makridakis M, Klein J, Mullen W, Abbas M, Stravodimos K, Katafigiotis I, Merseburger AS, Zoidakis J, Mischak H, Vlahou A, Jankowski V.

PLoS One. 2015 Sep 2;10(9):e0137048. doi: 10.1371/journal.pone.0137048. eCollection 2015. Erratum in: PLoS One. 2015;10(10):e0139268.

41.

Comparison of Depletion Strategies for the Enrichment of Low-Abundance Proteins in Urine.

Filip S, Vougas K, Zoidakis J, Latosinska A, Mullen W, Spasovski G, Mischak H, Vlahou A, Jankowski J.

PLoS One. 2015 Jul 24;10(7):e0133773. doi: 10.1371/journal.pone.0133773. eCollection 2015.

42.

Protein interactome of muscle invasive bladder cancer.

Bhat A, Heinzel A, Mayer B, Perco P, Mühlberger I, Husi H, Merseburger AS, Zoidakis J, Vlahou A, Schanstra JP, Mischak H, Jankowski V.

PLoS One. 2015 Jan 8;10(1):e0116404. doi: 10.1371/journal.pone.0116404. eCollection 2015.

43.

Evaluation of decellularization in umbilical cord artery.

Mallis P, Gontika I, Poulogiannopoulos T, Zoidakis J, Vlahou A, Michalopoulos E, Chatzistamatiou T, Papassavas A, Stavropoulos-Giokas C.

Transplant Proc. 2014 Nov;46(9):3232-9. doi: 10.1016/j.transproceed.2014.10.027.

PMID:
25420867
44.

Advances in urinary proteome analysis and applications in systems biology.

Filip S, Zoidakis J, Vlahou A, Mischak H.

Bioanalysis. 2014;6(19):2549-69. doi: 10.4155/bio.14.210. Review.

PMID:
25411698
45.

New selective peptidyl di(chlorophenyl) phosphonate esters for visualizing and blocking neutrophil proteinase 3 in human diseases.

Guarino C, Legowska M, Epinette C, Kellenberger C, Dallet-Choisy S, Sieńczyk M, Gabant G, Cadene M, Zoidakis J, Vlahou A, Wysocka M, Marchand-Adam S, Jenne DE, Lesner A, Gauthier F, Korkmaz B.

J Biol Chem. 2014 Nov 14;289(46):31777-91. doi: 10.1074/jbc.M114.591339. Epub 2014 Oct 6.

46.

Mass spectrometry-based membrane proteomics in cancer biomarker discovery.

Mermelekas G, Zoidakis J.

Expert Rev Mol Diagn. 2014 Jun;14(5):549-63. doi: 10.1586/14737159.2014.917965. Epub 2014 May 12. Review.

PMID:
24820261
47.

IMAC fractionation in combination with LC-MS reveals H2B and NIF-1 peptides as potential bladder cancer biomarkers.

Frantzi M, Zoidakis J, Papadopoulos T, Zürbig P, Katafigiotis I, Stravodimos K, Lazaris A, Giannopoulou I, Ploumidis A, Mischak H, Mullen W, Vlahou A.

J Proteome Res. 2013 Sep 6;12(9):3969-79. doi: 10.1021/pr400255h. Epub 2013 Aug 21.

PMID:
23924207
48.

Profilin 1 is a potential biomarker for bladder cancer aggressiveness.

Zoidakis J, Makridakis M, Zerefos PG, Bitsika V, Esteban S, Frantzi M, Stravodimos K, Anagnou NP, Roubelakis MG, Sanchez-Carbayo M, Vlahou A.

Mol Cell Proteomics. 2012 Apr;11(4):M111.009449. doi: 10.1074/mcp.M111.009449. Epub 2011 Dec 8.

49.

Comprehensive human urine standards for comparability and standardization in clinical proteome analysis.

Mischak H, Kolch W, Aivaliotis M, Bouyssié D, Court M, Dihazi H, Dihazi GH, Franke J, Garin J, Gonzalez de Peredo A, Iphöfer A, Jänsch L, Lacroix C, Makridakis M, Masselon C, Metzger J, Monsarrat B, Mrug M, Norling M, Novak J, Pich A, Pitt A, Bongcam-Rudloff E, Siwy J, Suzuki H, Thongboonkerd V, Wang LS, Zoidakis J, Zürbig P, Schanstra JP, Vlahou A.

Proteomics Clin Appl. 2010 Apr;4(4):464-78. doi: 10.1002/prca.200900189. Epub 2010 Feb 3.

50.

Supplemental Content

Loading ...
Support Center